Study Title and Description
Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial.
Key Questions Addressed
|3||KQ3a. What is the comparative effectiveness of nonpharmacologic therapy versus sham treatment, waitlist, usual care, attention control, and no treatment after followup at the following intervals: < 1 day; 1 day to <1 week; 1 week to <2 weeks; 2 weeks to 4 weeks? KQ3b. What is the comparative effectiveness of nonpharmacologic treatments (e.g. exercise, cognitive behavioral therapy, acupuncture, biofeedback, noninvasive neuromodulation devices) for outcomes related to pain, function, pain relief satisfaction, and quality of life? KQ3c. How does effectiveness of nonpharmacologic therapy vary depending on: (1) patient demographics (e.g. age, gender); (2) patient medical comorbidities? KQ3d. How do harms vary depending on: (1) patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of treatment used; (4) the frequency of therapy; (5) the duration of therapy?|
Primary Publication Information
|Title||Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial.|
|Author||Lipton RB., Dodick DW., Silberstein SD., Saper JR., Aurora SK., Pearlman SH., Fischell RE., Ruppel PL., Goadsby PJ.|
|Country||Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461, USA firstname.lastname@example.org|
Pubmed ID: 20206581
Secondary Publication Information
There are currently no secondary publications defined for this study.
Extraction Form: Key Question 3
|Question... Follow Up||Answer||Follow-up Answer|
Results & Comparisons
No Results found.